Prognostic Role of Interferon-λ3 in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Interstitial Lung Disease.
Atsuki FukadaTomoyuki FujisawaHironao HozumiKeigo KodaTaisuke AkamatsuYoshiyuki OyamaYasuomi SatakeMitsuru NiwaYusuke KaidaHiroyuki MatsudaKoshi YokomuraNaoki KoshimizuMikio ToyoshimaShiro ImokawaDai HashimotoAkira YoshidaTakahisa GonoMasataka KuwanaYasuhiko YamanoYasuhiro KondohKeita YamashitaMasato MaekawaKazutaka MoriYusuke InoueHideki YasuiYuzo SuzukiMasato KarayamaKazuki FuruhashiNoriyuki EnomotoNaoki InuiTakafumi SudaPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2024)
Serum IFNλ3 is a promising biomarker for identifying patients at high risk of poor outcomes in anti-MDA5 antibody-positive DM-ILD.
Keyphrases
- interstitial lung disease
- systemic sclerosis
- rheumatoid arthritis
- idiopathic pulmonary fibrosis
- end stage renal disease
- dendritic cells
- newly diagnosed
- immune response
- prognostic factors
- peritoneal dialysis
- genome wide
- systemic lupus erythematosus
- patient reported outcomes
- dna methylation
- metabolic syndrome
- disease activity
- transcription factor
- skin cancer
- genome wide identification